Genzyme Corp. announced that its diagnostics division hasacquired the business assets of Omnia Res srl to form Genzymesrl, which will remain in Milan Italy.
Omnia Res has been the sole distributor of Genzymeimmunobiological and research products to the Italian market.The terms of the transaction were not disclosed.
Just last week Genzyme (NASDAQ:GENZ) of Cambridge, Mass.,acquired a German diagnostics company, Virotech System-Diagnostika GmbH of Russelsheim, for about $10 million.
David Fleming, Genzyme Diagnostics' president, said that bothacquisitions are part of the company's long-term strategy todevelop its diagnostics business in Europe.
(c) 1997 American Health Consultants. All rights reserved.